Zivo Bioscience Warrants Insiders
ZIVOWDelisted Stock | USD 0.55 0.07 14.58% |
Zivo Bioscience employs about 8 people. The company is managed by 7 executives with a total tenure of roughly 19 years, averaging almost 2.0 years of service per executive, having 1.14 employees per reported executive. Recap of Zivo Bioscience's management performance can provide insight into the venture performance.
Zivo |
Zivo Bioscience Management Team Effectiveness
The company has return on total asset (ROA) of (1.6474) % which means that it has lost $1.6474 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (39.5602) %, meaning that it generated substantial loss on money invested by shareholders. Zivo Bioscience's management efficiency ratios could be used to measure how well Zivo Bioscience manages its routine affairs as well as how well it operates its assets and liabilities.Zivo Bioscience Workforce Comparison
Zivo Bioscience Warrants is rated second in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 38.0. Zivo Bioscience totals roughly 8.0 in number of employees claiming about 21% of equities under Health Care industry.
Zivo Bioscience Notable Stakeholders
A Zivo Bioscience stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Zivo Bioscience often face trade-offs trying to please all of them. Zivo Bioscience's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Zivo Bioscience's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
John Payne | CEO President | Profile | |
Casey Fowler | VP Devel | Profile | |
David Lafond | VP Technology | Profile | |
Harlan III | Vice Supply | Profile | |
Keith Marchiando | Treasurer CFO | Profile | |
Andrew Dahl | CEO Pres | Profile | |
Scott Freeman | Chief Officer | Profile |
About Zivo Bioscience Management Performance
The success or failure of an entity such as Zivo Bioscience Warrants often depends on how effective the management is. Zivo Bioscience management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Zivo management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Zivo management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Please note, the imprecision that can be found in Zivo Bioscience's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Zivo Bioscience Warrants. Check Zivo Bioscience's Beneish M Score to see the likelihood of Zivo Bioscience's management manipulating its earnings.
Zivo Bioscience Workforce Analysis
Traditionally, organizations such as Zivo Bioscience use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Zivo Bioscience within its industry.Zivo Bioscience Manpower Efficiency
Return on Zivo Bioscience Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 1.1M | |
Net Loss Per Executive | 1.2M |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Stocks Directory module to find actively traded stocks across global markets.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience Warrants check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |